Search Results 481-490 of 13215 for Ponstel

1. Study Of Targeted Therapies For The Treatment Of Adult Participants With Moderate To Severe Crohn's Disease - Mayo Clinic

   Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels ...

2. A Study To Evaluate The Safety, Pharmacokinetics And Pharmacodynamics Of ABBV-181 (Budigalimab) In Adult Participants With HIV-1 - Mayo Clinic

   The purpose of this study is to test (in 2 stages) the safety/tolerability, pharmacokinetics (how the body handles study drug) and pharmacodynamics (effects on ...

3. Neurology - Clinical trials - Mayo Clinic

   We will identify innate immune cell populations that contribute to astrocyte reactivity and elucidate the mechanisms responsible for altering the ...

4. Testing The Addition Of Duvelisib Or CC-486 To The Usual Treatment For Peripheral T-Cell Lymphoma - Mayo Clinic

   Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

5. A Study To Evaluate Safety And Effectiveness Of PRM-151 To Treat Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

   The purpose of this study is to confirm the long-term safety, effectiveness, and pharmacokinetics of PRM-151 in the treatment of eligible patients with IPF who ...

6. Back pain - Doctors and departments - Mayo Clinic

   Back pain is one of the most common reasons people seek medical help. Home treatment and proper body mechanics often can treat back pain within a few weeks.

7. A Study To Test The Safety And Effectiveness Of PF-00547659 For Patients Who Have Crohn's Disease - Mayo Clinic

   The purpose of this study is to assess the safety and effectiveness of PF-00547659 (experimental drug) for patients who have Crohn's disease that is clinically ...

8. Integrative medicine - Doctors & Departments - Mayo Clinic

   This type of medicine adds complementary and alternative medicine (CAM) practices to mainstream medicine.

9. A Study to Provide Access to CTL019 Out of Specification Managed Access Program (MAP) for ALL or DLBCL Patients - Mayo Clinic

   The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...

10. Gastroenterology and Hepatology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.